CASP3 and Alzheimer disease: Meanwhile, the covered areas of activated caspase-3 were significantly reduced by approximately 55% in the cortex and by 57% in the hippocampus of the RJ group compared to the AD model group (all p < 0.01), indicating that RJ can inhibit neuronal apoptosis.